Vor Biopharma Inc
VOR
NASDAQ
Biotechnology
$23.03
USD
-0.26 (-1.12%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.20B
Volume 417.5K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$627.78M
TTM
+137.7%
YoY
Operating Cash Flow
$-140.09M
TTM
-23.3%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 12.8 | 14.0 | 16.8 | 17.6 | 21.9 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 274.3 | 28.1 | 36.0 | 35.2 | 47.9 |
Operating Income | -274.3 | -28.1 | -36.0 | -35.2 | -47.9 |
EBITDA | -272.2 | -28.1 | -35.9 | -35.1 | -47.8 |
Other Income / Expense | -1,299.9 | -786.3 | 1,756.0 | -188.4 | -19.3 |
Total Other Income / Expense | -1,299.4 | -784.6 | 1,758.8 | -184.4 | -15.0 |
Income Before Income Taxes | -1,573.7 | -812.7 | 1,722.9 | -219.6 | -62.8 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -1,573.7 | -812.7 | 1,722.9 | -219.6 | -62.8 |
Consolidated Net Income / Loss | -1,573.7 | -812.7 | 1,722.9 | -219.6 | -62.8 |
Net Income Attributable to Common Shareholders | -1,573.7 | -812.7 | 1,722.9 | -219.6 | -62.8 |
Basic EPS | -$251.24 | -$121.63 | $84.87 | -$5.11 | -$1.16 |
Diluted EPS | -$251.24 | -$121.63 | $84.87 | -$5.11 | -$1.16 |
Basic Shares Outstanding | 6.3M | 6.7M | 20.3M | 43.0M | 54.3M |
Diluted Shares Outstanding | 6.3M | 6.7M | 20.3M | 43.0M | 54.3M |